2004
DOI: 10.1159/000081275
|View full text |Cite
|
Sign up to set email alerts
|

Very Late Central Nervous System Relapse in a Patient with B Cell Lymphoblastic Lymphoma

Abstract: Very late relapse of lymphoblastic lymphoma (LBL) is very rare. We report a case of a patient who developed central nervous system (CNS) relapse of LBL 16 years after the onset of the primary disease. An 8-year-old girl was hospitalized with a skin tumor in the occipital region on November 27, 1984. Examination of a biopsy of the skin tumor showed typical features of non-Hodgkin’s lymphoma (diffuse medium-sized cell type). She received multiagent chemotherapy and went into remission. On July 4, 2000, she was h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…T-cell type usually presents with a mediastinal mass and cervical lymphadenopathy. However, B-LBL often occurs within skin and bone involvement, except for a small proportion involving soft tissue and presenting with a mass lesion [5,6]. Localized invasion of peripheral nerves of extra-nodal LBL, a unique uncommon subtype, was termed as neurolymphomatosis [7].…”
Section: Discussionmentioning
confidence: 99%
“…T-cell type usually presents with a mediastinal mass and cervical lymphadenopathy. However, B-LBL often occurs within skin and bone involvement, except for a small proportion involving soft tissue and presenting with a mass lesion [5,6]. Localized invasion of peripheral nerves of extra-nodal LBL, a unique uncommon subtype, was termed as neurolymphomatosis [7].…”
Section: Discussionmentioning
confidence: 99%
“…This report aims to provide insights into the cutaneous manifestations of neoplasms with a blastic morphology, focusing on the blastoid variant of mantle cell lymphoma (MCL) 23,[23][24][25][26][27][28][29][30][31][31][32][33][34][35][36][37][38][39][40][41][42], T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL), and B-cell acute lymphoblastic leukemia/lymphoma (B-ALL/LBL) [43][44][45][46][47][48][49][50][51][52][53]53,54,[54][55][56][57][58], through an accurate review of the pertinent literature.…”
Section: Introductionmentioning
confidence: 99%